Organizations  >  DC-THERA Partner  >  Centre d'Immunology Marseil...

Centre d'Immunology Marseille-Luminy

DC-THERA Partner


The Centre d’Immunologie de Marseille-Luminy (CIML) created in 1976 is a Research Institute attached to the CNRS, Inserm and the Université de la Méditerranée.

This center of excellence is part of the Luminy science campus, that comprises fundamental research laboratories and biotech start-ups located between Marseilles and Cassis on the mediterranean coast.
Since 2004, the CIML has been relocated in one new and fully equipped 6.000 m2 building, the construction of which was possible thanks to the CNRS, Inserm, ARC, the city of Marseilles, the Bouches-du-Rhône County and the Provence-Alpes-Côte d’Azur Region.

230 people work at CIML. They are distributed among 20 research teams, administration, technical services and scientific common services including imaging, proteomics, transgenesis facilities and three scientific platforms: microscopy (PICsL platform), bio-optics (MOSAIC platform) and functional exploration of the mouse model (RIO-Marseille-Nice Genopole platform).

The main Immunology-based areas of research investigated by CIML teams are: ontogeny, lymphocyte and myeloid cell activation and differentiation, phagocytosis, host-pathogen interactions and cell death.
Ciml 2000

The organization of the CIML is very unique in France. It is a federation of research teams, the size and the duration of which are limited. The Director is elected for a four-year term that can be renewed only once. Mutualisation of most of resources allows synergies and high-scale savings. Another specificity is that CIML has been successful in hiring researchers from foreign countries (eight group leaders are from abroad). In addition, long-term collaborative efforts have been established between CIML, universities, hospitals and private companies (four biotechs emerged from the work of CIML scientists: Immunotech, Innate Pharma, Ipsogen, Oz Bioscience).

The future of the Centre d’Immunologie is guaranteed by the presence of several modules of laboratories that have been kept empty for future new teams with scientific programs able to complement already on site studies and/or to bring forward more relationship with companies. CIML scientific activity is submitted to a strong evaluation system controlled by an external international Scientific Advisory Board working in close contact with the National Evaluation Committees from Inserm and CNRS.


     [ RDF Rdf ]   [ RelFinder Relfinder ]